Showing results (41-50 of 690) with videos related to
Sort By:
Pageof 69
Cancer Research|October 24, 2012
Tryptophan catabolism in cancer: beyond IDO and tryptophan depletionMichael Platten, Wolfgang Wick, Benoît J Van den EyndeNature Nanotechnology|August 26, 2024
Bottom-up synthetic immunologyKerstin Göpfrich, Michael Platten, Friedrich Frischknecht, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Antiangiogenic therapy for glioblastoma: the challenge of translating response rate into efficacyJohn de Groot, David A Reardon, Tracy T BatchelorExpert Review of Anticancer Therapy|May 12, 2007
Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patientsDavid A Reardon, Michael R Zalutsky, Darell D BignerExpert Opinion on Investigational Drugs|December 11, 2013
Current status of antiangiogenic therapies for glioblastomasIsabel Arrillaga-Romany, David A Reardon, Patrick Y WenNeuro-Oncology|October 25, 2014
Targeted molecular therapies against epidermal growth factor receptor: past experiences and challengesDavid A Reardon, Patrick Y Wen, Ingo K MellinghoffInternational Journal of Molecular Sciences|December 10, 2021
Genetically Modified Cellular Therapies for Malignant GliomasMichael Kilian, Theresa Bunse, Wolfgang Wick, et al.Biochemical Pharmacology|September 25, 2003
Involvement of protein kinase Cdelta and extracellular signal-regulated kinase-2 in the suppression of microglial inducible nitric oxide synthase expression by N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast)Michael Platten, Katrin Eitel, Jörg Wischhusen, et al.Nature Reviews. Cancer|May 18, 2026
Regulation of immune checkpoint molecules in cancer immune evasion and therapyCansu Eris, Cheng Zu, Yanling Xiao, et al.Journal of the Neurological Sciences|April 23, 2021
Sex-related differences in stressful events precipitating transient global amnesia - A retrospective observational studyCarolin Hoyer, Anne Ebert, Vesile Sandikci, et al.Pageof 69